Horizon Inks Screening Deal with SuperGen | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has inked an agreement with SuperGen, under which it will provide screening services for the biopharmaceutical firm's drug candidates using its X-MAN technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.